Adrienne Farid
Chief Operating Officer bei CENTURY THERAPEUTICS, INC.
Vermögen: 577 463 $ am 31.03.2024
Profil
Adrienne Farid is currently the Chief Operations Officer at Century Therapeutics, Inc. She previously worked as a Director at Carisma Therapeutics, Inc., VP-Project Leadership at Celgene Corp., and Global Head-Project & Portfolio Management at Roche Pharmaceuticals, Inc. Farid holds a doctorate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Barnard College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.03.2024 | 138 149 ( 0,17% ) | 577 463 $ | 31.03.2024 |
Aktive Positionen von Adrienne Farid
| Unternehmen | Position | Beginn |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Chief Operating Officer | 01.04.2021 |
Ehemalige bekannte Positionen von Adrienne Farid
| Unternehmen | Position | Ende |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01.07.2017 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01.01.2011 |
| CARISMA THERAPEUTICS, INC. | Director/Board Member | - |
Ausbildung von Adrienne Farid
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Barnard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CENTURY THERAPEUTICS, INC. | Health Technology |
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
